# FDA Inspection 1201080 - Biomat USA, Inc. - March 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e4b9367d-678d-40ac-9980-13fe7ae81e76
Source feed: FDA_Inspections

> FDA Inspection 1201080 for Biomat USA, Inc. on March 24, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201080
- Company Name: Biomat USA, Inc.
- Inspection Date: 2023-03-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1201080 - 2023-03-24](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/51f77d5e-81f1-4bf7-888b-0db932f0bcdf)
- [FDA Inspection 1039319 - 2018-02-01](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c0373e11-1ba4-4db2-9682-283a58cb0d52)
- [FDA Inspection 835567 - 2013-06-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/949fc6e4-460b-47e4-89c5-5c35d75eda2b)
- [FDA Inspection 747161 - 2011-09-28](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/093aa39b-ce78-4378-b69a-e35d85e92b01)

Company: https://www.keypedia.com/companies/biomat-usa-inc/07396b1c-e99b-4699-bce4-4e111e2b04ef

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d